Table of Contents
Introduction
Methylxanthines are a class of drugs that include theophylline, aminophylline, and caffeine. They are primarily used as bronchodilators in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). In addition to respiratory effects, they also have central nervous system stimulant and cardiovascular effects. Their mechanism of action involves multiple pathways, including phosphodiesterase inhibition and adenosine receptor antagonism.
Mechanism of Action (Step-wise)
- Methylxanthines inhibit phosphodiesterase (PDE) enzymes, particularly PDE3 and PDE4.
- Inhibition of PDE prevents breakdown of cyclic AMP (cAMP).
- Increased cAMP levels in smooth muscle cells lead to activation of protein kinase A (PKA).
- This results in reduced intracellular calcium levels.
- Reduced calcium causes relaxation of bronchial smooth muscle (bronchodilation).
- Methylxanthines also antagonize adenosine receptors (A1 and A2).
- Adenosine normally causes bronchoconstriction and CNS depression.
- Blocking adenosine receptors reduces bronchoconstriction and stimulates the CNS.
- They may also enhance diaphragmatic contractility and improve respiratory muscle function.
- Additional effects include mild anti-inflammatory action and increased catecholamine release.
A key exam point is that methylxanthines act by PDE inhibition (↑ cAMP) and adenosine receptor blockade.
Pharmacokinetics
Methylxanthines are administered orally or intravenously. They are well absorbed and widely distributed in body tissues. They are metabolized in the liver, primarily via cytochrome P450 enzymes (especially CYP1A2). Their half-life varies depending on age, liver function, and drug interactions. Theophylline has a narrow therapeutic index, requiring careful monitoring of plasma levels. Elimination occurs mainly through renal excretion of metabolites.
Clinical Uses
Methylxanthines are used in the management of asthma and COPD as bronchodilators. They are particularly useful in patients who do not respond adequately to other therapies. Caffeine, another methylxanthine, is used in neonatal apnea to stimulate respiration. They also improve diaphragmatic contractility, which can be beneficial in respiratory failure.
Adverse Effects
Methylxanthines have a narrow therapeutic index, and toxicity is dose-related. Common adverse effects include nausea, vomiting, insomnia, and restlessness. More serious effects include arrhythmias and seizures. CNS stimulation and cardiovascular effects are prominent at higher doses. Drug interactions are common due to hepatic metabolism.
Comparative Analysis
| Feature | Methylxanthines | β2 Agonists | Anticholinergics |
|---|---|---|---|
| Mechanism | PDE inhibition + adenosine blockade | β2 receptor stimulation | Muscarinic blockade |
| cAMP effect | Increased | Increased | No direct effect |
| Bronchodilation | Yes | Yes | Yes |
| CNS effect | Stimulant | Minimal | Minimal |
| Therapeutic index | Narrow | Wide | Wide |
| Use | Asthma, COPD | First-line asthma | COPD, asthma |
Methylxanthines differ from β2 agonists in that they increase cAMP by inhibiting its breakdown rather than stimulating its production. They also have CNS stimulant effects, which are absent in most other bronchodilators.
MCQs
- Methylxanthines inhibit which enzyme?
a) Cyclooxygenase
b) Phosphodiesterase
c) DNA polymerase
d) ATP synthase
Answer: b) Phosphodiesterase
- PDE inhibition leads to increased levels of:
a) cGMP
b) cAMP
c) ATP
d) ADP
Answer: b) cAMP
- Increased cAMP causes:
a) Bronchoconstriction
b) Bronchodilation
c) Vasoconstriction
d) Muscle contraction
Answer: b) Bronchodilation
- Methylxanthines also block:
a) Dopamine receptors
b) Adenosine receptors
c) Serotonin receptors
d) Histamine receptors
Answer: b) Adenosine receptors
- Adenosine normally causes:
a) Bronchodilation
b) Bronchoconstriction
c) Muscle growth
d) Insulin release
Answer: b) Bronchoconstriction
- Methylxanthines are used in:
a) Hypertension
b) Asthma
c) Diabetes
d) Anemia
Answer: b) Asthma
- Which drug is a methylxanthine?
a) Salbutamol
b) Theophylline
c) Ipratropium
d) Prednisone
Answer: b) Theophylline
- Methylxanthines improve:
a) Liver function
b) Diaphragm contractility
c) Renal filtration
d) Bone density
Answer: b) Diaphragm contractility
- A major adverse effect is:
a) Hypoglycemia
b) Arrhythmia
c) Hypercalcemia
d) Bradycardia
Answer: b) Arrhythmia
- Methylxanthines are metabolized in the:
a) Kidney
b) Liver
c) Lung
d) Brain
Answer: b) Liver
- Methylxanthines have which therapeutic index?
a) Wide
b) Narrow
c) Moderate
d) Variable
Answer: b) Narrow
- CNS stimulation is due to:
a) GABA activation
b) Adenosine blockade
c) Calcium blockade
d) Sodium influx
Answer: b) Adenosine blockade
FAQs
What is the mechanism of action of methylxanthines?
They inhibit phosphodiesterase and block adenosine receptors, leading to increased cAMP and bronchodilation.
Why do methylxanthines cause CNS stimulation?
Because they block adenosine receptors, which normally produce CNS depression.
Why is monitoring required with theophylline?
Due to its narrow therapeutic index.
What is the role of methylxanthines in asthma?
They act as bronchodilators and improve respiratory muscle function.
What are major adverse effects?
Arrhythmias, seizures, and CNS stimulation.
Are methylxanthines first-line drugs?
No, they are usually used when other treatments are insufficient.
References
Goodman & Gilman’s The Pharmacological Basis of Therapeutics – Respiratory Drugs
https://accessmedicine.mhmedical.com/book.aspx?bookid=3191
Katzung: Basic and Clinical Pharmacology – Bronchodilators
https://accessmedicine.mhmedical.com/content.aspx?bookid=3382
Tripathi: Essentials of Medical Pharmacology – Respiratory Drugs
https://www.jaypeedigital.com
Harrison’s Principles of Internal Medicine – Asthma & COPD
https://accessmedicine.mhmedical.com
